Short answer
Texas had 167 pharmaceutical and medicine manufacturing establishments in 2023, 4th among states, employing 9,884 people at an average annual pay of $75,555 (Census County Business Patterns). 110 of them have fewer than 20 employees. Harris (29) and Dallas (25) counties have the most. Drug wholesalers employ 16,918. FDA's file lists sites for Alcon in Fort Worth, Allergan in Waco and FUJIFILM in College Station. biote of Irving is the largest listed drugmaker based in Texas.
- Texas drug plants average 59 employees and $75,555 in pay, against $147,967 in California.
- Drug wholesale establishments (608, with 16,918 jobs) employ about 1.7 times as many people as the plants.
- 65 of Texas's 357 FDA drug registrations are medicated animal feed mills, 9 of them in Hereford.
- Only 18 Texas drug plants have 100 or more employees; 110 have fewer than 20.
- No listed drugmaker headquartered in Texas reported more than $200 million of revenue in 2025.
On this page
Use this report if you're looking for drug companies in Texas to work for, partner with or sell to. It counts plants with Census data, names registered sites from FDA's file and checks the listed companies in their 10-Ks. The city reports go deeper: Houston and Dallas.
Texas in the Census data
County Business Patterns (CBP) 2023, NAICS 3254 (Pharmaceutical and Medicine Manufacturing):
| Measure (2023) | Texas |
|---|---|
| Establishments | 167 |
| Employees | 9,884 |
| Annual payroll | $746,787,000 |
| Average employees per establishment | 59.2 |
| Average annual pay | $75,555 |
| Share of US establishments | 5.76% of 2,901 |
| Rank among states by establishments | 4th |
| Employees per establishment | Establishments |
|---|---|
| 1 to 4 | 65 |
| 5 to 9 | 25 |
| 10 to 19 | 20 |
| 20 to 49 | 17 |
| 50 to 99 | 22 |
| 100 to 249 | 11 |
| 250 to 499 | not published |
| 500 to 999 | 4 |
| 1,000 or more | not published |
The Census Bureau doesn't publish the 250 to 499 or the 1,000 or more cells for Texas. Together they hold 3 establishments, the total less the published classes, so 18 Texas plants have 100 or more employees, against 110 with fewer than 20. By product, 82 establishments make finished-dose pharmaceuticals (325412, 6,000 employees), 48 make medicinal chemicals and botanicals (325411, 1,252), 22 make biological products (325414, 1,456) and 15 make diagnostic substances (325413, 1,176).
Why the low pay? The product mix explains much of it. Dividing CBP payroll by employees, Texas biological product plants paid $107,878 on average in 2023, medicinal chemical and botanical plants $75,611 and finished-dose plants $69,559 (our calculation). Texas has far more of the last two.
| County | Establishments | Employees |
|---|---|---|
| Harris | 29 | 1,276 |
| Dallas | 25 | 640 |
| Bexar | 14 | not reported (high-noise figure) |
| Collin | 12 | 498 |
| Tarrant | 12 | 928 |
| Travis | 12 | not reported (high-noise figure) |
| Fort Bend | 7 | 813 |
| Montgomery | 6 | 216 |
"Not reported" means the Census Bureau published the figure but flagged it as high-noise: its confidentiality noise moved the value by 5% or more. CBP counts plants and other locations with paid employees, not companies, and doesn't count the self-employed.
Distribution is the bigger industry
Code 3254 counts plants only. Head offices, research labs and distribution centers have their own codes, and in Texas the distributors dominate: 608 drug wholesale establishments (NAICS 424210) with 16,918 employees in 2023. That code also covers wholesalers of vitamins, botanicals and cosmetics, so not every site handles prescription drugs. Biotechnology R&D (NAICS 541714) adds 257 establishments with 4,041 employees.
What FDA's registration file shows
FDA's Drug Establishments Current Registration Site (DECRS) is the public list of registered drug sites. We counted 357 Texas registrations in the 30 October 2026 download:
| Type (our classification) | Registrations |
|---|---|
| Make finished drugs or active ingredients | 131 |
| Medical gas suppliers (by firm name) | 85 |
| Medicated animal feed mills | 65 |
| Pack, label or relabel only | 41 |
| Testing only | 15 |
| PET imaging drugs and other | 20 |
Houston and Dallas have 30 registrations each, Fort Worth 20. Hereford has 9, nearly all feedyards and feed mills registered to make medicated feed. The larger manufacturing names include Alcon Research in Fort Worth, Allergan Sales and Pacific Pharma in Waco (both registered to Allergan, Inc.), FUJIFILM Diosynth Biotechnologies in College Station, AstraZeneca in Coppell and Lonza in Houston (active ingredients), DPT Laboratories in San Antonio, Mission Pharmacal in Boerne, Sovereign Pharmaceuticals in Fort Worth and Otsuka ICU Medical in Austin. Consumer companies such as Mary Kay in Lewisville are registered too, for over-the-counter products. None of this means FDA has approved a site; companies file their own registrations.
The state's Economic Development and Tourism office names FUJIFILM Diosynth, Alcon, Galderma, Novartis and Taysha Gene Therapies among life sciences companies with a strong presence in Texas.
Listed drug companies headquartered in Texas
SEC EDGAR shows 29 listed companies in SIC codes 2833 to 2836 with a Texas business address. Checked in each latest 10-K:
| Company | Headquarters (10-K cover) | Revenue, 2025 | Employees reported |
|---|---|---|---|
| biote (hormone therapy practice platform) | Irving | $192.2 million | 223 |
| Mannatech (nutritional supplements) | Flower Mound | $108.0 million | 170 |
| Lexicon Pharmaceuticals | The Woodlands | $49.8 million | 81 (2 March 2026) |
| Alpha Cognition | Grapevine | $10.2 million | 72 full-time |
| Taysha Gene Therapies | Dallas | $9.8 million | 99 |
| Aspira Women's Health (diagnostics) | Austin | $9.2 million | 36 full-time |
| Coya Therapeutics | Houston | $7.9 million | 8 full-time |
| Marker Therapeutics | Houston | $3.5 million (grants) | 5 full-time |
| Shattuck Labs | Austin | $1.0 million | 40 full-time |
Two companies EDGAR files under Texas give other addresses on their latest 10-K covers: CG Oncology (Irvine, California) and Savara (Langhorne, Pennsylvania). The global companies behind the big Texas sites report from elsewhere; see the largest pharmaceutical companies.
Checking a Texas company
- Licence. FDA lists the Texas Department of State Health Services as the agency that licenses wholesale drug distributors in the state. Ask any distributor or logistics partner for its state licence number.
- FDA record. FDA's Data Dashboard shows inspections, warning letters and recalls for each registered site.
- Product type. Check what a registrant actually makes: a "manufacturer" in the file may be a feed mill, a gas filler or a cosmetics brand.
- Local networks. BioHouston, based in the Texas Medical Center, runs a jobs board for its members and regular events.
Selling to Texas drug companies
| Segment | Size (CBP) | Who decides |
|---|---|---|
| Global sites (Fort Worth, Waco, College Station, Coppell) | 18 plants with 100 or more | Site leadership with corporate procurement |
| Mid-size makers and contract manufacturers | 39 with 20 to 99 | Plant or operations manager |
| Small makers | 110 with fewer than 20 | Owner or one quality lead |
Worked example: a quality systems consultancy
Illustrative example. The firm and its fees are invented; the counts come from CBP 2023 and FDA's registration file.
Brazos Quality Partners (brazosquality.example) writes and audits GMP quality systems for small drug and OTC makers.
- Find the small makers. 110 plants with fewer than 20 employees, cross-checked against the 131 manufacturing registrations to find who makes what.
- Screen out the wrong fits. Drop gas fillers and feed mills, which follow different rules, and keep finished-dose, botanical and OTC makers.
- Do the arithmetic. If 60 accounts remain, 1 in 5 takes a gap audit at $9,000 and half of those buy a $30,000 remediation project, that's $108,000 plus $180,000, or $288,000.
Sorting real drugmakers from cosmetics brands and feed mills is the slow part; Bebop researches each account and explains why it fits.
Next step: compare a state with fewer plants but far larger ones in the North Carolina pharmaceutical market report.
Sources
- County Business Patterns (CBP), 2023, US Census Bureau, accessed 30 October 2026
- 2023 County Business Patterns datasets (state and county files, NAICS 3254, 424210 and 541714), US Census Bureau, accessed 30 October 2026
- County Business Patterns methodology (noise flags), US Census Bureau, accessed 30 October 2026
- Drug Establishments Current Registration Site (DECRS), US Food and Drug Administration, accessed 30 October 2026
- DECRS annual registration status download (drls_reg.zip), US Food and Drug Administration, accessed 30 October 2026
- Check licensure of wholesale drug distributors and third-party logistics providers, US Food and Drug Administration, accessed 30 October 2026
- FDA Data Dashboard, US Food and Drug Administration, accessed 30 October 2026
- Biotechnology and life sciences, Office of the Texas Governor, Economic Development and Tourism, accessed 30 October 2026
- BioHouston, BioHouston, accessed 30 October 2026
- biote Corp. Form 10-K for 2025, biote Corp., via SEC EDGAR, filed 13 March 2026
- Mannatech Form 10-K for 2025, Mannatech, Incorporated, via SEC EDGAR, filed 15 April 2026
- Lexicon Pharmaceuticals Form 10-K for 2025, Lexicon Pharmaceuticals, Inc., via SEC EDGAR, filed 5 March 2026
- Alpha Cognition Form 10-K for 2025, Alpha Cognition Inc., via SEC EDGAR, filed 31 March 2026
- Taysha Gene Therapies Form 10-K for 2025, Taysha Gene Therapies, Inc., via SEC EDGAR, filed 19 March 2026
- Aspira Women's Health Form 10-K for 2025, Aspira Women's Health Inc., via SEC EDGAR, filed 1 April 2026
- Coya Therapeutics Form 10-K for 2025, Coya Therapeutics, Inc., via SEC EDGAR, filed 16 March 2026
- Marker Therapeutics Form 10-K for 2025, Marker Therapeutics, Inc., via SEC EDGAR, filed 18 March 2026
- Shattuck Labs Form 10-K for 2025, Shattuck Labs, Inc., via SEC EDGAR, filed 5 March 2026
- CG Oncology Form 10-K for 2025 (cover page address), CG Oncology, Inc., via SEC EDGAR, filed 27 February 2026
- Savara Form 10-K for 2025 (cover page address), Savara Inc., via SEC EDGAR, filed 13 March 2026
Written by the Bebop team at Blackpearl Group. Published .
Questions people ask
How many pharmaceutical companies are in Texas?
Census County Business Patterns counted 167 pharmaceutical and medicine manufacturing establishments in Texas in 2023, fourth among states, with 9,884 employees. Texas also had 608 drug wholesale establishments with 16,918 employees. FDA's drug registration file lists 357 registered sites, including gas suppliers and feed mills, and SEC EDGAR shows 29 listed drug companies with a Texas address.
What are the biggest pharmaceutical companies in Texas?
No large listed drugmaker is headquartered in Texas: the biggest by 2025 revenue in its 10-K is biote of Irving ($192.2 million), followed by Mannatech and Lexicon Pharmaceuticals. The large drug sites belong to companies based elsewhere. FDA's file lists Alcon Research in Fort Worth, Allergan in Waco, FUJIFILM Diosynth in College Station, AstraZeneca in Coppell and Lonza in Houston.
Where are pharmaceutical plants in Texas?
Census data puts the most drug manufacturing establishments in Harris County (29), Dallas County (25), Bexar County (14) and Collin, Tarrant and Travis counties (12 each). FDA's registration file shows the most registered drug sites in Houston and Dallas (30 each), Fort Worth (20), San Antonio (12) and Austin (11).
Why do pharmaceutical jobs in Texas pay less than in other states?
Texas drug plants paid an average of $75,555 per employee in 2023, according to Census County Business Patterns, against $147,967 in California and $94,639 in North Carolina. Texas plants are smaller (59 employees on average) and most make finished-dose drugs or botanicals; by our division of Census payroll, those paid $69,559 and $75,611 a year, against $107,878 at Texas biologics plants.